- Five-year follow-up of nivolumab in previously treated advanced non–small-cell lung cancer: Results from the CA209-003 Study
- Comparing ultraviolet light A photo(chemo)therapy with Methotrexate protocol in childhood localized Scleroderma: Evidence from systematic review and meta-analysis approach
- Association of cerebrospinal fluid biomarkers of central nervous system injury with neurocognitive and brain imaging outcomes in children receiving chemotherapy for acute lymphoblastic leukemia
- Comparison of effects of anagliptin and alogliptin on serum lipid profile in type 2 diabetes mellitus patients
- Association of placebo, indomethacin, ibuprofen, and acetaminophen with closure of hemodynamically significant patent ductus arteriosus in preterm infants: A systematic review and meta-analysis
- Bivalirudin vs heparin with primary percutaneous coronary intervention
- Switching from abacavir to tenofovir disoproxil fumarate is associated with rises in soluble glycoprotein VI, suggesting changes in platelet–collagen interactions
- Prospective international randomized phase II study of low-dose abiraterone with food vs standard dose abiraterone in castration-resistant prostate cancer
- Valganciclovir is beneficial in children with congenital cytomegalovirus and isolated hearing loss
- A randomized double-blind placebo-controlled study comparing intracoronary vs intravenous abciximab in patients with ST-elevation myocardial infarction undergoing transradial rescue percutaneous coronary intervention after failed thrombolysis
- The effects of an oral taurine dose and supplementation period on endurance exercise performance in humans: A meta-analysis
- What non-carbapenem antibiotics are active against ESBL-producing <em>Enterobacteriaceae</em>?
- Effectiveness and safety of direct oral anticoagulants and warfarin, stratified by stroke risk in patients with atrial fibrillation
- The frequency of nonsteroidal anti-inflammatory drug hypersensitivity in children with asthma
- Randomised phase III trial of concurrent chemoradiotherapy with extended nodal irradiation and erlotinib in patients with inoperable oesophageal squamous cell cancer
Feed Sources
